맞춤형 항체 시장(2025-2029년)

The global custom antibody market is forecasted to grow by USD 305.2 mn during 2024-2029, accelerating at a CAGR of 9.3% during the forecast period. The report on the global custom antibody market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing research and development investments in biopharmaceuticals and personalized medicine, technological advancements in antibody engineering and production, growing demand for high-quality reagents in diagnostics and life sciences research.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global custom antibody market is segmented as below:

By Type

• Monoclonal antibodies
• Polyclonal antibodies
• Recombinant antibodies
• Others

By Source

• Rabbit
• Mice
• Others

By Application

• Oncology
• Infectious disease
• Immunology
• Neurology
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • The Netherlands
  • Italy
  • Spain
  • Russia
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the rise of recombinant and engineered antibodies as one of the prime reasons driving the global custom antibody market growth during the next few years. Also, integration of artificial intelligence and machine learning in antibody discovery and growing adoption of single b-cell screening technologies will lead to sizable demand in the market.

The report on the global custom antibody market covers the following areas:

• Global custom antibody market sizing
• Global custom antibody market forecast
• Global custom antibody market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global custom antibody market vendors that include Abcam plc, Abmart, Agilent Technologies Inc., Bio Rad Laboratories Inc., BioLegend Inc., Cell Signaling Technology Inc., Creative Diagnostics, GenScript Biotech Corp., Kaneka Eurogentec SA, Laboratory Corp., LifeSpan BioSciences Inc., Merck KGaA, ProMab Biotechnologies, Inc, Proteo Genix, RayBiotech Life Inc., Rockland Immunochemicals Inc., Thermo Fisher Scientific Inc., YenZym Antibodies, LLC. Also, the global custom antibody market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Source
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029

5 Historic Market Size

• 5.1 Global Custom Antibody Market 2019 - 2023
  • Historic Market Size - Data Table on Global Custom Antibody Market 2019 - 2023 ($ million)
• 5.2 Type segment analysis 2019 - 2023
  • Historic Market Size - Type Segment 2019 - 2023 ($ million)
• 5.3 Source segment analysis 2019 - 2023
  • Historic Market Size - Source Segment 2019 - 2023 ($ million)
• 5.4 Application segment analysis 2019 - 2023
  • Historic Market Size - Application Segment 2019 - 2023 ($ million)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI in the Global Custom Antibody Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition

8 Market Segmentation by Type

• 8.1 Market segments
• 8.2 Comparison by Type
• 8.3 Monoclonal antibodies - Market size and forecast 2024-2029
• 8.4 Polyclonal antibodies - Market size and forecast 2024-2029
• 8.5 Recombinant antibodies - Market size and forecast 2024-2029
• 8.6 Others - Market size and forecast 2024-2029
• 8.7 Market opportunity by Type
  • Market opportunity by Type ($ million)

9 Market Segmentation by Source

• 9.1 Market segments
• 9.2 Comparison by Source
• 9.3 Rabbit - Market size and forecast 2024-2029
• 9.4 Mice - Market size and forecast 2024-2029
• 9.5 Others - Market size and forecast 2024-2029
• 9.6 Market opportunity by Source
  • Market opportunity by Source ($ million)

10 Market Segmentation by Application

• 10.1 Market segments
• 10.2 Comparison by Application
• 10.3 Oncology - Market size and forecast 2024-2029
• 10.4 Infectious disease - Market size and forecast 2024-2029
• 10.5 Immunology - Market size and forecast 2024-2029
• 10.6 Neurology - Market size and forecast 2024-2029
• 10.7 Others - Market size and forecast 2024-2029
• 10.8 Market opportunity by Application
  • Market opportunity by Application ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • 12.3.1 US - Market size and forecast 2024-2029
  • 12.3.2 Canada - Market size and forecast 2024-2029
  • 12.3.3 Mexico - Market size and forecast 2024-2029
• 12.4 Europe - Market size and forecast 2024-2029
  • 12.4.1 Germany - Market size and forecast 2024-2029
  • 12.4.2 UK - Market size and forecast 2024-2029
  • 12.4.3 France - Market size and forecast 2024-2029
  • 12.4.4 The Netherlands - Market size and forecast 2024-2029
  • 12.4.5 Italy - Market size and forecast 2024-2029
  • 12.4.6 Spain - Market size and forecast 2024-2029
  • 12.4.7 Russia - Market size and forecast 2024-2029
• 12.5 Asia - Market size and forecast 2024-2029
  • 12.5.1 China - Market size and forecast 2024-2029
  • 12.5.2 Japan - Market size and forecast 2024-2029
  • 12.5.3 India - Market size and forecast 2024-2029
  • 12.5.4 South Korea - Market size and forecast 2024-2029
  • 12.5.5 Indonesia - Market size and forecast 2024-2029
  • 12.5.6 Thailand - Market size and forecast 2024-2029
  • 12.5.7 Singapore - Market size and forecast 2024-2029
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • 12.6.1 Australia - Market size and forecast 2024-2029
  • 12.6.2 Brazil - Market size and forecast 2024-2029
  • 12.6.3 South Africa - Market size and forecast 2024-2029
  • 12.6.4 UAE - Market size and forecast 2024-2029
  • 12.6.5 Saudi Arabia - Market size and forecast 2024-2029
  • 12.6.6 Turkey - Market size and forecast 2024-2029
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Increasing research and development investments in biopharmaceuticals and personalized medicine
  • Technological advancements in antibody engineering and production
  • Growing demand for high-quality reagents in diagnostics and life sciences research
• 13.2 Market challenges
  • High costs and long timelines associated with custom antibody development
  • Stringent regulatory requirements and complex validation processes
  • Technical complexities and high risk of project failure
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities
  • Rise of recombinant and engineered antibodies
  • Integration of artificial intelligence and machine learning in antibody discovery
  • Growing adoption of single B-cell screening technologies

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abcam plc
  • Abcam plc - Overview
  • Abcam plc - Product / Service
  • Abcam plc - Key news
  • Abcam plc - Key offerings
  • SWOT
• 15.5 Abmart
  • Abmart - Overview
  • Abmart - Product / Service
  • Abmart - Key offerings
  • SWOT
• 15.6 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 15.7 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 15.8 BioLegend Inc.
  • BioLegend Inc. - Overview
  • BioLegend Inc. - Product / Service
  • BioLegend Inc. - Key offerings
  • SWOT
• 15.9 Cell Signaling Technology Inc.
  • Cell Signaling Technology Inc. - Overview
  • Cell Signaling Technology Inc. - Product / Service
  • Cell Signaling Technology Inc. - Key offerings
  • SWOT
• 15.10 Creative Diagnostics
  • Creative Diagnostics - Overview
  • Creative Diagnostics - Product / Service
  • Creative Diagnostics - Key offerings
  • SWOT
• 15.11 GenScript Biotech Corp.
  • GenScript Biotech Corp. - Overview
  • GenScript Biotech Corp. - Business segments
  • GenScript Biotech Corp. - Key news
  • GenScript Biotech Corp. - Key offerings
  • GenScript Biotech Corp. - Segment focus
  • SWOT
• 15.12 Kaneka Eurogentec SA
  • Kaneka Eurogentec SA - Overview
  • Kaneka Eurogentec SA - Product / Service
  • Kaneka Eurogentec SA - Key offerings
  • SWOT
• 15.13 Laboratory Corp.
  • Laboratory Corp. - Overview
  • Laboratory Corp. - Business segments
  • Laboratory Corp. - Key news
  • Laboratory Corp. - Key offerings
  • Laboratory Corp. - Segment focus
  • SWOT
• 15.14 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
  • SWOT
• 15.15 ProMab Biotechnologies, Inc
  • ProMab Biotechnologies, Inc - Overview
  • ProMab Biotechnologies, Inc - Product / Service
  • ProMab Biotechnologies, Inc - Key offerings
  • SWOT
• 15.16 Rockland Immunochemicals Inc.
  • Rockland Immunochemicals Inc. - Overview
  • Rockland Immunochemicals Inc. - Product / Service
  • Rockland Immunochemicals Inc. - Key offerings
  • SWOT
• 15.17 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT
• 15.18 YenZym Antibodies, LLC
  • YenZym Antibodies, LLC - Overview
  • YenZym Antibodies, LLC - Product / Service
  • YenZym Antibodies, LLC - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations